← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 1995Last known activity
Oct 1, 2024
Timeline
1900s
- Jan 1, 1904
Swedish Heart Lung Foundation— Founded
Drugs by trial phase (22 distinct, 16 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (8 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (9 own, 0 via acquisition)
Indications
Recent trials (16)
- NCT06515730CollaboratorPhase 4Oct 1, 2024
- NCT05852704CollaboratorPhase 4Oct 2, 2023
- NCT05939076CollaboratorPhase 3Aug 21, 2023
- NCT05241327CollaboratorN/AJan 1, 2022
- NCT05260827CollaboratorN/AOct 1, 2021
- NCT02831608CollaboratorPhase 4Oct 1, 2016
- NCT02683213CollaboratorPhase 3Oct 1, 2014
- NCT02326428CollaboratorN/AMar 1, 2014
- NCT01787110CollaboratorPhase 3Apr 1, 2013
- NCT03551184CollaboratorN/AOct 31, 2010
- NCT03551080CollaboratorN/AOct 31, 2009
- NCT02294955CollaboratorN/AMay 1, 2008
- NCT02022176CollaboratorN/AMar 31, 2008
- NCT01357109CollaboratorPhase 2Nov 1, 2007
- NCT00543452CollaboratorN/AFeb 28, 2005
Details
- Founded
- Stockholm, SE Jan 1, 1904
- Last known activity
- Oct 1, 2024